Your browser doesn't support javascript.
loading
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore.
Laas, Enora; Labrosse, Julie; Hamy, Anne-Sophie; Benchimol, Gabriel; de Croze, Diane; Feron, Jean-Guillaume; Coussy, Florence; Balezeau, Thomas; Guerin, Julien; Lae, Marick; Pierga, Jean-Yves; Reyal, Fabien.
Afiliação
  • Laas E; Department of Surgery, Institut Curie, Paris, France.
  • Labrosse J; Department of Surgery, Institut Curie, Paris, France.
  • Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.
  • Benchimol G; Department of Surgery, Institut Curie, Paris, France.
  • de Croze D; Department of Medical Oncology, Institut Curie, Paris, France.
  • Feron JG; Department of Surgery, Institut Curie, Paris, France.
  • Coussy F; Department of Medical Oncology, Institut Curie, Paris, France.
  • Balezeau T; Data Office, Institut Curie, 26 rue d'Ulm, 75005, Paris, France.
  • Guerin J; Data Office, Institut Curie, 26 rue d'Ulm, 75005, Paris, France.
  • Lae M; Department of Pathology, Institut Curie, Paris, France.
  • Pierga JY; Department of Medical Oncology, Institut Curie, Paris, France.
  • Reyal F; Department of Surgery, Institut Curie, Paris, France. fabien.reyal@curie.fr.
Br J Cancer ; 124(8): 1421-1427, 2021 04.
Article em En | MEDLINE | ID: mdl-33558711
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França